Home Biotechnology Whole Exome Sequencing Market Size to Surpass USD 9.8 billion at a CAGR of 21.5% by 2032

Whole Exome Sequencing Market Size, Share & Trends Analysis Report By Products (Systems, Kits, Services), By Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Others), By Applications (Diagnostics, Cancer, Monogenic Disorders, Diabetes, Drug Discovery and Development, Personalized Medicine, Agriculture and Animal Research, Others), By End-user (Research Center, Academic and Government Institutions, Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, Others) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2024-2032

Report Code: SRBI56118DR
Last Updated : May 13, 2024
Author : Straits Research
Starting From
USD 2300
Buy Now

Table Of Content

  1. Executive Summary

    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends

    1. Global Whole Exome Sequencing Market Introduction
    2. By Products
      1. Introduction
        1. Products By Value
      2. Systems
        1. By Value
      3. Kits
        1. By Value
      4. Services
        1. By Value
    3. By Technology
      1. Introduction
        1. Technology By Value
      2. Sequencing by Synthesis
        1. By Value
      3. Ion Semiconductor Sequencing
        1. By Value
      4. Others
        1. By Value
    4. By Applications
      1. Introduction
        1. Applications By Value
      2. Diagnostics
        1. By Value
      3. Cancer
        1. By Value
      4. Monogenic Disorders
        1. By Value
      5. Diabetes
        1. By Value
      6. Drug Discovery and Development
        1. By Value
      7. Personalized Medicine
        1. By Value
      8. Agriculture and Animal Research
        1. By Value
      9. Others
        1. By Value
    5. By End-user
      1. Introduction
        1. End-user By Value
      2. Research Center
        1. By Value
      3. Academic and Government Institutions
        1. By Value
      4. Hospitals and Clinics
        1. By Value
      5. Pharmaceutical and Biotechnology Companies
        1. By Value
      6. Others
        1. By Value
    1. Introduction
    2. By Products
      1. Introduction
        1. Products By Value
      2. Systems
        1. By Value
      3. Kits
        1. By Value
      4. Services
        1. By Value
    3. By Technology
      1. Introduction
        1. Technology By Value
      2. Sequencing by Synthesis
        1. By Value
      3. Ion Semiconductor Sequencing
        1. By Value
      4. Others
        1. By Value
    4. By Applications
      1. Introduction
        1. Applications By Value
      2. Diagnostics
        1. By Value
      3. Cancer
        1. By Value
      4. Monogenic Disorders
        1. By Value
      5. Diabetes
        1. By Value
      6. Drug Discovery and Development
        1. By Value
      7. Personalized Medicine
        1. By Value
      8. Agriculture and Animal Research
        1. By Value
      9. Others
        1. By Value
    5. By End-user
      1. Introduction
        1. End-user By Value
      2. Research Center
        1. By Value
      3. Academic and Government Institutions
        1. By Value
      4. Hospitals and Clinics
        1. By Value
      5. Pharmaceutical and Biotechnology Companies
        1. By Value
      6. Others
        1. By Value
    6. U.S.
      1. By Products
        1. Introduction
          1. Products By Value
        2. Systems
          1. By Value
        3. Kits
          1. By Value
        4. Services
          1. By Value
      2. By Technology
        1. Introduction
          1. Technology By Value
        2. Sequencing by Synthesis
          1. By Value
        3. Ion Semiconductor Sequencing
          1. By Value
        4. Others
          1. By Value
      3. By Applications
        1. Introduction
          1. Applications By Value
        2. Diagnostics
          1. By Value
        3. Cancer
          1. By Value
        4. Monogenic Disorders
          1. By Value
        5. Diabetes
          1. By Value
        6. Drug Discovery and Development
          1. By Value
        7. Personalized Medicine
          1. By Value
        8. Agriculture and Animal Research
          1. By Value
        9. Others
          1. By Value
      4. By End-user
        1. Introduction
          1. End-user By Value
        2. Research Center
          1. By Value
        3. Academic and Government Institutions
          1. By Value
        4. Hospitals and Clinics
          1. By Value
        5. Pharmaceutical and Biotechnology Companies
          1. By Value
        6. Others
          1. By Value
    7. Canada
    1. Introduction
    2. By Products
      1. Introduction
        1. Products By Value
      2. Systems
        1. By Value
      3. Kits
        1. By Value
      4. Services
        1. By Value
    3. By Technology
      1. Introduction
        1. Technology By Value
      2. Sequencing by Synthesis
        1. By Value
      3. Ion Semiconductor Sequencing
        1. By Value
      4. Others
        1. By Value
    4. By Applications
      1. Introduction
        1. Applications By Value
      2. Diagnostics
        1. By Value
      3. Cancer
        1. By Value
      4. Monogenic Disorders
        1. By Value
      5. Diabetes
        1. By Value
      6. Drug Discovery and Development
        1. By Value
      7. Personalized Medicine
        1. By Value
      8. Agriculture and Animal Research
        1. By Value
      9. Others
        1. By Value
    5. By End-user
      1. Introduction
        1. End-user By Value
      2. Research Center
        1. By Value
      3. Academic and Government Institutions
        1. By Value
      4. Hospitals and Clinics
        1. By Value
      5. Pharmaceutical and Biotechnology Companies
        1. By Value
      6. Others
        1. By Value
    6. U.K.
      1. By Products
        1. Introduction
          1. Products By Value
        2. Systems
          1. By Value
        3. Kits
          1. By Value
        4. Services
          1. By Value
      2. By Technology
        1. Introduction
          1. Technology By Value
        2. Sequencing by Synthesis
          1. By Value
        3. Ion Semiconductor Sequencing
          1. By Value
        4. Others
          1. By Value
      3. By Applications
        1. Introduction
          1. Applications By Value
        2. Diagnostics
          1. By Value
        3. Cancer
          1. By Value
        4. Monogenic Disorders
          1. By Value
        5. Diabetes
          1. By Value
        6. Drug Discovery and Development
          1. By Value
        7. Personalized Medicine
          1. By Value
        8. Agriculture and Animal Research
          1. By Value
        9. Others
          1. By Value
      4. By End-user
        1. Introduction
          1. End-user By Value
        2. Research Center
          1. By Value
        3. Academic and Government Institutions
          1. By Value
        4. Hospitals and Clinics
          1. By Value
        5. Pharmaceutical and Biotechnology Companies
          1. By Value
        6. Others
          1. By Value
    7. Germany
    8. France
    9. Spain
    10. Italy
    11. Russia
    12. Nordic
    13. Benelux
    14. Rest of Europe
    1. Introduction
    2. By Products
      1. Introduction
        1. Products By Value
      2. Systems
        1. By Value
      3. Kits
        1. By Value
      4. Services
        1. By Value
    3. By Technology
      1. Introduction
        1. Technology By Value
      2. Sequencing by Synthesis
        1. By Value
      3. Ion Semiconductor Sequencing
        1. By Value
      4. Others
        1. By Value
    4. By Applications
      1. Introduction
        1. Applications By Value
      2. Diagnostics
        1. By Value
      3. Cancer
        1. By Value
      4. Monogenic Disorders
        1. By Value
      5. Diabetes
        1. By Value
      6. Drug Discovery and Development
        1. By Value
      7. Personalized Medicine
        1. By Value
      8. Agriculture and Animal Research
        1. By Value
      9. Others
        1. By Value
    5. By End-user
      1. Introduction
        1. End-user By Value
      2. Research Center
        1. By Value
      3. Academic and Government Institutions
        1. By Value
      4. Hospitals and Clinics
        1. By Value
      5. Pharmaceutical and Biotechnology Companies
        1. By Value
      6. Others
        1. By Value
    6. China
      1. By Products
        1. Introduction
          1. Products By Value
        2. Systems
          1. By Value
        3. Kits
          1. By Value
        4. Services
          1. By Value
      2. By Technology
        1. Introduction
          1. Technology By Value
        2. Sequencing by Synthesis
          1. By Value
        3. Ion Semiconductor Sequencing
          1. By Value
        4. Others
          1. By Value
      3. By Applications
        1. Introduction
          1. Applications By Value
        2. Diagnostics
          1. By Value
        3. Cancer
          1. By Value
        4. Monogenic Disorders
          1. By Value
        5. Diabetes
          1. By Value
        6. Drug Discovery and Development
          1. By Value
        7. Personalized Medicine
          1. By Value
        8. Agriculture and Animal Research
          1. By Value
        9. Others
          1. By Value
      4. By End-user
        1. Introduction
          1. End-user By Value
        2. Research Center
          1. By Value
        3. Academic and Government Institutions
          1. By Value
        4. Hospitals and Clinics
          1. By Value
        5. Pharmaceutical and Biotechnology Companies
          1. By Value
        6. Others
          1. By Value
    7. Korea
    8. Japan
    9. India
    10. Australia
    11. Singapore
    12. Taiwan
    13. South East Asia
    14. Rest of Asia-Pacific
    1. Introduction
    2. By Products
      1. Introduction
        1. Products By Value
      2. Systems
        1. By Value
      3. Kits
        1. By Value
      4. Services
        1. By Value
    3. By Technology
      1. Introduction
        1. Technology By Value
      2. Sequencing by Synthesis
        1. By Value
      3. Ion Semiconductor Sequencing
        1. By Value
      4. Others
        1. By Value
    4. By Applications
      1. Introduction
        1. Applications By Value
      2. Diagnostics
        1. By Value
      3. Cancer
        1. By Value
      4. Monogenic Disorders
        1. By Value
      5. Diabetes
        1. By Value
      6. Drug Discovery and Development
        1. By Value
      7. Personalized Medicine
        1. By Value
      8. Agriculture and Animal Research
        1. By Value
      9. Others
        1. By Value
    5. By End-user
      1. Introduction
        1. End-user By Value
      2. Research Center
        1. By Value
      3. Academic and Government Institutions
        1. By Value
      4. Hospitals and Clinics
        1. By Value
      5. Pharmaceutical and Biotechnology Companies
        1. By Value
      6. Others
        1. By Value
    6. UAE
      1. By Products
        1. Introduction
          1. Products By Value
        2. Systems
          1. By Value
        3. Kits
          1. By Value
        4. Services
          1. By Value
      2. By Technology
        1. Introduction
          1. Technology By Value
        2. Sequencing by Synthesis
          1. By Value
        3. Ion Semiconductor Sequencing
          1. By Value
        4. Others
          1. By Value
      3. By Applications
        1. Introduction
          1. Applications By Value
        2. Diagnostics
          1. By Value
        3. Cancer
          1. By Value
        4. Monogenic Disorders
          1. By Value
        5. Diabetes
          1. By Value
        6. Drug Discovery and Development
          1. By Value
        7. Personalized Medicine
          1. By Value
        8. Agriculture and Animal Research
          1. By Value
        9. Others
          1. By Value
      4. By End-user
        1. Introduction
          1. End-user By Value
        2. Research Center
          1. By Value
        3. Academic and Government Institutions
          1. By Value
        4. Hospitals and Clinics
          1. By Value
        5. Pharmaceutical and Biotechnology Companies
          1. By Value
        6. Others
          1. By Value
    7. Turkey
    8. Saudi Arabia
    9. South Africa
    10. Egypt
    11. Nigeria
    12. Rest of MEA
    1. Introduction
    2. By Products
      1. Introduction
        1. Products By Value
      2. Systems
        1. By Value
      3. Kits
        1. By Value
      4. Services
        1. By Value
    3. By Technology
      1. Introduction
        1. Technology By Value
      2. Sequencing by Synthesis
        1. By Value
      3. Ion Semiconductor Sequencing
        1. By Value
      4. Others
        1. By Value
    4. By Applications
      1. Introduction
        1. Applications By Value
      2. Diagnostics
        1. By Value
      3. Cancer
        1. By Value
      4. Monogenic Disorders
        1. By Value
      5. Diabetes
        1. By Value
      6. Drug Discovery and Development
        1. By Value
      7. Personalized Medicine
        1. By Value
      8. Agriculture and Animal Research
        1. By Value
      9. Others
        1. By Value
    5. By End-user
      1. Introduction
        1. End-user By Value
      2. Research Center
        1. By Value
      3. Academic and Government Institutions
        1. By Value
      4. Hospitals and Clinics
        1. By Value
      5. Pharmaceutical and Biotechnology Companies
        1. By Value
      6. Others
        1. By Value
    6. Brazil
      1. By Products
        1. Introduction
          1. Products By Value
        2. Systems
          1. By Value
        3. Kits
          1. By Value
        4. Services
          1. By Value
      2. By Technology
        1. Introduction
          1. Technology By Value
        2. Sequencing by Synthesis
          1. By Value
        3. Ion Semiconductor Sequencing
          1. By Value
        4. Others
          1. By Value
      3. By Applications
        1. Introduction
          1. Applications By Value
        2. Diagnostics
          1. By Value
        3. Cancer
          1. By Value
        4. Monogenic Disorders
          1. By Value
        5. Diabetes
          1. By Value
        6. Drug Discovery and Development
          1. By Value
        7. Personalized Medicine
          1. By Value
        8. Agriculture and Animal Research
          1. By Value
        9. Others
          1. By Value
      4. By End-user
        1. Introduction
          1. End-user By Value
        2. Research Center
          1. By Value
        3. Academic and Government Institutions
          1. By Value
        4. Hospitals and Clinics
          1. By Value
        5. Pharmaceutical and Biotechnology Companies
          1. By Value
        6. Others
          1. By Value
    7. Mexico
    8. Argentina
    9. Chile
    10. Colombia
    11. Rest of LATAM
    1. Whole Exome Sequencing Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Thermo Fisher Scientific, Inc.
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Illumina, Inc
    3. Agilent Technologies, Inc
    4. BBG
    5. PacBio
    6. Oxford Nanopore Technologies plc.
    7. Azenta US Inc. (GENEWIZ)
    8. CD Genomics
    9. Novogene Co Ltd
    10. Eurofins Genomics
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
Genome Sequencing Market Size The global genome sequencing market size was valued at USD 41.92 billion in 2023 and is projected to reach USD 101.23 billion by 2032, growing at a CAGR of 11.7% during the forecast period (2024–2032). Genome sequencin
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report


We are featured on :